Poeder: | Nee |
---|---|
Aangepaste: | Aangepaste |
Certificering: | GMP, ISO 9001, USP, BP |
Geschikt voor: | Ouderen, Kinderen, Volwassen |
Staat: | Solide |
Zuiverheid: | > 99% |
Leveranciers met geverifieerde zakelijke licenties
Roxithromycin Is een halfsynthetisch macrolide antibioticum. Het wordt gebruikt om ademhalingskanaal, urine en zachte weefselbesmettingen te behandelen. Roxithromycin wordt afgeleid uit erythromycin, die de zelfde membered lactone 14 ring bevatten. Nochtans, is een n-Oxime zijketen in bijlage aan de lactone ring. Het ondergaat ook momenteel klinische proeven voor de behandeling van het verlies van het mannelijk-patroonhaar
De Naam van het product | Roxin |
Contects | Roxithromycin 150mg |
Formeulation | tablet of capsule |
Toepassing | Antibiotisch |
Opslag | Opslag onder 25oC. Protect van licht |
Roxithromycin | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - imino 10 (((2-methoxyethoxy) methoxy)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid A van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - 3, 5, 7, 9, 11, 13-hexamethyloxacyclotetradecane-2, 10-dione |
De Onzuiverheid B van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - imino 14-ethyl-4. 7.12.13-tetrahydroxy-10 (((2-methoxyethoxy) methoxy)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid C van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - 10 (hydroxyimino) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid D van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, Z) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - imino 10 (((2-methoxyethoxy) methoxy)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid E van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - 4 (((2R, 4R, 5S, 6S) - 4.5-dihydroxy-4.6-dimethyltetrahydro-2H-pyran-2) oxy) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - imino 14-ethyl-7.12.13-trihydroxy-10 (((2-methoxyethoxy) methoxy)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid F van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2) oxy) - oxy 6 (((2S, 3R, 4S, 6R) - 3-hydroxy-6-methyl-4 (methylamino) tetrahydro-2H-pyran-2)) - imino 10 (((2-methoxyethoxy) methoxy)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid G van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - methoxy 10 ((((2-methoxyethoxy) methoxy)) imino) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid H van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13R, 14R, E) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12-dihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - imino 10 (((2-methoxyethoxy) methoxy)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
Onzuiverheid I van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3 - ((2-methoxyethoxy) methoxy) - oxy 6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - imino 10 (((2-methoxyethoxy) methoxy)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid J van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - imino 10 (((2-chloroethoxy) methoxy)) - 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2) oxy) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Onzuiverheid K van Roxithromycin (EP) | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - methoxy 10 ((((hydroxymethoxy) ethoxy 2)) imino) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
De Isomeer van de Onzuiverheid B van Roxithromycin | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, Z) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - imino 14-ethyl-4. 7.12.13-tetrahydroxy-10 (((2-methoxyethoxy) methoxy)) - 3.5.7.9.11.13-hexamethyloxacyclotetradecan-2- |
2-Hydroxymethyl Roxithromycin | (3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R, E) - oxy 6 (((2S, 3R, 4S, 6R) - 4 (dimethylamino) - 3-hydroxy-6-methyltetrahydro-2H-pyran-2)) - oxy 14-ethyl-7.12.13-trihydroxy-4 (((2R, 4R, 5S, 6S) - 5-hydroxy-4-methoxy-4.6-dimethyltetrahydro-2H-pyran-2)) - 3 (hydroxymethyl) - imino 10 (((2-methoxyethoxy) methoxy)) - 5.7.9.11.13-pentamethyloxacyclotetradecan-2- |
Leveranciers met geverifieerde zakelijke licenties